Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2014

Stellar Biotechnologies, Inc. (SBOTF) Continues to Dominate KLH Production, Rocks the 2014 TSXV 50, New Verification Method Developed

Stellar Biotechnologies has drawn considerable attention over the past year or so for their incredible work developing Keyhole Limpet Hemocyanin (KLH), a high-impact T-dependent carrier protein for naturally catalyzing immune responses (MHC Class I and Class II-restricted), which is generally … Continue reading

Posted in Small Cap News | Leave a comment

VolitionRx Ltd. (VNRX) Pioneering Cancer Diagnostics for Growing Colorectal Cancer Incidences

VolitionRx is a publicly traded life sciences company that is developing innovative solutions for blood-based diagnostics for different types of cancers. The company believes that current diagnostics techonologies are inadequate, so is focusing its efforts on developing earlier, more cost-effective … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

IEC Electronics Corp. (IEC) Adds New Board Member

Premier provider of electronic manufacturing services, IEC Electronics announced earlier today that John C. Johnson will be joining its Board of Directors. Johnson has held a number of executive roles and retired as senior executive with Northrop Grumman Corporation. Most … Continue reading

Posted in Small Cap News | Leave a comment

Boston Therapeutics, Inc. (BTHE) Inks Consulting Agreement to Launch SugarDown® in U.S. Market

Boston Therapeutics, a developer of complex carbohydrate chemistry-based drugs that address diabetes, has signed a consulting agreement with Generosus Advisors, LLC and Fortified Management Group, LLC to market the SugarDown® dietary supplement in the United States on a non-exclusive basis. … Continue reading

Posted in Small Cap News | Leave a comment

Chembio Diagnostics, Inc. (CEMI) Signs Two Agreements with RVR Diagnostics SDN BHD

Chembio Diagnostics announced today that it has entered into two agreements with RVR Diagnostics SDN BHD, a privately held company in Malaysia, where RVR will become a licensee, distributor, and contract manufacturer of Chembio products. The agreements are in line … Continue reading

Posted in Small Cap News | Leave a comment

Merge Healthcare Inc. (MRGE) Trailblazing 2014 EHR Meaningful Use Compliance in Radiology Imaging, Web-Enabled Interoperability

Merge Healthcare, which has already made a name for itself in enterprise-class medical imaging and scalable laboratory information systems, as well as in interoperability solutions that make it easy to use and share all this rich data, dropped some huge … Continue reading

Posted in Small Cap News | Leave a comment

Methes Energies International Ltd. (MEIL) Offers Impressive Range of Biodiesel Solutions

Methes Energies is an innovative best-in-class company providing a suite of biodiesel solutions targeted at large and small scale biodiesel producers, as well as entrepreneurs seeking the independence of producing their own fuel. The company’s team possesses an impeccable reputation … Continue reading

Posted in Methes Energies International MEIL | Leave a comment

Support.com, Inc. (SPRT) and Park Associates to Present Webcast Titled “Supporting the Connected Home: Preventing the Internet of Broken Things”

Support.com, a prominent supplier of cloud-based technology services and software, will be presenting a free webcast with market research firm Parks Associates on February 20, 2014 at 11 AM PST / 2 PM EST. The presentation is titled “Supporting the … Continue reading

Posted in Small Cap News | Leave a comment

Iveda (IVDA) Board of Directors Names Bob Brilon as President

Pioneer in cloud video hosting technology, Iveda announced that Bob Brilon has been recruited to the role of president by its Board of Directors. Brilon will report directly to CEO and Chairman David Ly. He will also continue on as … Continue reading

Posted in Small Cap News | Leave a comment

VistaGen Therapeutics, Inc. (VSTA) Highlights Drug Rescue Potential at Noble Financial Capital Markets’ 9th Annual Equity Conference

VistaGen Therapeutics is a California-based biotechnology company that specializes in the application of human pluripotent stem cell (hPSC) technology for drug rescue, including predictive toxicology and drug metabolism screening. The company’s hPSC technology platform, Human Clinical Trials in a Test … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment